ADVANCE__ID Profile Banner
ADVANCE-ID Network Profile
ADVANCE-ID Network

@ADVANCE__ID

Followers
755
Following
369
Media
64
Statuses
248

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is a global network for infectious disease clinical studies.

Singapore
Joined February 2023
Don't wanna be here? Send us removal request.
@ADVANCE__ID
ADVANCE-ID Network
9 days
On 8 and 9 December, ADVANCE-ID hosted the REACH Asia Online Forum, bringing together experts to discuss the importance of engaging communities for clinical trials. Read more: https://t.co/OgYBegXTaL
0
0
1
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
17 days
💻 GARDP is hosting a webinar on the progress and lessons from 5 BY 25, our multi-year effort to advance new antibiotic treatments that address major innovation and access gaps. 📅 15 January 2026 ⏰ 12:00–13:00 CET We will share key results, insights on today’s antibiotic
1
5
14
@ADVANCE__ID
ADVANCE-ID Network
13 days
Last week, the ADVANCE-ID team had the opportunity to visit Rumah Sakit Nasional Dr. Cipto Mangunkusumo (@rscm_official), #OUCRU #Indonesia, and the Indonesia Clinical Research Center (INA-CRC) teams in #Jakarta. đź”—Read more: https://t.co/IInUSJs2SZ #ClinicalTrials #collaborate
0
0
3
@ADVANCE__ID
ADVANCE-ID Network
19 days
We're delighted to share that the our Thai Public Engagement Hub led by the Institute of HIV Research and Innovation (IHRI), Thailand successfully conducted its first Community Advisory Group meeting for the Promoting Community Engagement in Clinical Trials in Asia project.
1
0
0
@ADVANCE__ID
ADVANCE-ID Network
25 days
✨ We’re are pleased to introduce Mr Huang Xiangyuan and welcome him to the ADVANCE-ID team! Learn more about him in this brief profile. #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
0
3
3
@ADVANCE__ID
ADVANCE-ID Network
26 days
🏆 Dr Mo Yin, Deputy Director of ADVANCE-ID, has been awarded the L’Oréal-UNESCO For Women in Science Award 2025 (Singapore)! 👩‍🔬✨ “AMR is a silent pandemic, and this recognition reinforces the urgency of rigorous science.” 👏 🔗 Find out more: https://t.co/W7aZqaIfTL #AMR #NUS
0
0
2
@ADVANCE__ID
ADVANCE-ID Network
1 month
CARB-X has released updated eligibility criteria for 2025 Funding Round (opens from 1–12 Dec): therapeutics for Gram‑negative infections and Diagnostics for Salmonella Typhi for low resource settings Join webinars on 4–5 Dec. Find out more: https://t.co/ruisx1nEXH
0
2
1
@ADVANCE__ID
ADVANCE-ID Network
1 month
✨ We’re are pleased to introduce Dr Xiao Tingting and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile. #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
0
0
2
@ADVANCE__ID
ADVANCE-ID Network
1 month
Join us on 8–9 Dec 2025 for the REACH Asia Forum on Community Engagement! Hear from experts and community leaders across the region on strengthening community engagement and participation in health research. Register at 🔗 https://t.co/ZLKQ4Vigmi #CommunityEngagement
0
3
7
@ADVANCE__ID
ADVANCE-ID Network
1 month
We’re delighted to share highlights from our recent workshop “Framing JUST solutions for ACCESS to treatment against AMR”! Fantastic participants, candid challenge-sharing, and lively, solutions-focused discussions throughout the day. Read more: https://t.co/WhhFKEI7E2
0
3
2
@ADVANCE__ID
ADVANCE-ID Network
2 months
đź§Ş Share Your AMR Research at #ACC2026 now! Abstract Submission Open Until 14 Nov 2025. Organized by @gardp_amr , @BSACandJAC , @ADVANCE__ID & @MahidolU đź—“ Submission deadline: Friday, 14 Nov 2025 đź”— Submit your abstract: https://t.co/HeWMKJKayy #AMR #AbstractSubmission
0
5
3
@ADVANCE__ID
ADVANCE-ID Network
2 months
New research led by Dr Mo Yin from ADVANCE-ID (NUS) finds that some individuals can carry multidrug-resistant E. coli for extended periods and at high amounts, potentially spreading it. Find out more: Lianhe Zaobao: https://t.co/3ndL2KcqZX NUS Medicine: https://t.co/uODLFG2NVZ
0
2
5
@ADVANCE__ID
ADVANCE-ID Network
2 months
What do you think are the overlooked priorities in antimicrobial resistance mitigation strategies? Share your top 3: Link: https://t.co/6i5uQEWcGv ⏱ Takes <3 minutes @OhemuPius @TexasTech
0
3
6
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
3 months
👩‍💻 How can #AI transform microbiology? Join Adrian Egli & Javier Fernández Domínguez at our next #REVIVE webinar to take a closer look at how AI is being used to analyse microbiological data and predict antimicrobial susceptibility. 📅 28 Oct | 17:00 CET 🔗 Register:
0
3
5
@ADVANCE__ID
ADVANCE-ID Network
2 months
Proud to join @WHO’s new GCTF to advance equitable, ethical & impactful research worldwide. Together with NUS SSHSPH, ADVANCE-ID will help strengthen Asia’s trial ecosystems - training local teams, innovating designs & fostering collaboration. Read more: https://t.co/WjApGKNKsx
0
1
5
@ADVANCE__ID
ADVANCE-ID Network
3 months
Read more here:
0
0
0
@ADVANCE__ID
ADVANCE-ID Network
3 months
NUS Medicine has received a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support DETECT-Asia (Strengthening Diagnostics for sEvere bacTErial infeCTions in Asia) to enhance the #diagnostics for severe bacterial infections and fight #AMR.
1
0
2
@ADVANCE__ID
ADVANCE-ID Network
3 months
ADVANCE-ID Directors make presentations at the inaugural Global AMR Innovators Conference (GAMRIC), London, October 1 and 2, 2025. Read more: https://t.co/HNbYAU0x3b #GAMRIC2025
0
1
8
@ADVANCE__ID
ADVANCE-ID Network
3 months
🌍 Passionate about clinical microbiology & AMR? Join us in our Microbiology Interest Group! We would love to connect with microbiologists, ID physicians, fellows, lab staff & managers - All levels of experience are welcome! 📩 Contact Dr Alec Aligui: alec.aligui@u.nus.edu
0
1
4